Research study Program year 2022 Source: CMS Open Payments

Lucentis Dosing Retreatment

Research payments

$36,736

10 payments

Through program year 2022, $36,736 in research payments was reported against Lucentis Dosing Retreatment, across 10 payments, paid by F. Hoffmann-La Roche AG.

Paid by: F. Hoffmann-La Roche AG
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$10,895	4
2021	Research	$25,841	6

Breakdown

Who paid Research payments · program years 2021–2022

F. Hoffmann-La Roche AG $36,736 10 payments

Who received the money Research payments · program years 2021–2022

Srinivas Sadda Ophthalmology · Pasadena, CA $11,951 2 payments
David Lally Ophthalmology · Springfield, MA $6,681 1 payment
David Sarraf Ophthalmology · Los Angeles, CA $4,889 1 payment
Nancy Holekamp Ophthalmology · Chesterfield, MO $4,889 1 payment
Glenn Yiu Retina Specialist · Sacramento, CA $2,946 1 payment
Marco Zarbin Ophthalmology · Newark, NJ $1,548 1 payment
Veeral Sheth Ophthalmology · Oak Forest, IL $1,543 1 payment
Jesse Jung Ophthalmology · Oakland, CA $1,145 1 payment
Kenneth Freund Ophthalmology · New York, NY $1,145 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.